These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 19015958)

  • 41. Molecular therapy in support to radiotherapy.
    Dutreix M; Cosset JM; Sun JS
    Mutat Res; 2010; 704(1-3):182-9. PubMed ID: 20067843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of gene therapy in regenerative surgery: updated insights.
    Giatsidis G; Venezia ED; Bassetto F
    Plast Reconstr Surg; 2013 Jun; 131(6):1425-1435. PubMed ID: 23714802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanoscale microenvironment engineering based on layer-by-layer self-assembly to regulate hair follicle stem cell fate for regenerative medicine.
    Chen P; Miao Y; Zhang F; Huang J; Chen Y; Fan Z; Yang L; Wang J; Hu Z
    Theranostics; 2020; 10(25):11673-11689. PubMed ID: 33052240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell-Free Approaches and Therapeutic Biomolecules for Cardiac Regeneration.
    Gyöngyösi M
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33530565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antisense oligonucleotides as a powerful molecular strategy for gene therapy in cardiovascular diseases.
    Tomita N; Morishita R
    Curr Pharm Des; 2004; 10(7):797-803. PubMed ID: 15032704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
    J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nucleic acid-based techniques for post-transcriptional regulation of molecular targets.
    Jarad G; Simske JS; Sedor JR; Schelling JR
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):415-21. PubMed ID: 12815338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Regenerative medicine for rheumatoid arthritis--current status and problems].
    Adachi N; Ochi M
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():666-71. PubMed ID: 15799439
    [No Abstract]   [Full Text] [Related]  

  • 49. RNA interference in mammalian cell systems.
    Lochmatter D; Mullis PE
    Horm Res Paediatr; 2011; 75(1):63-9. PubMed ID: 21252559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concise Review: Human Dermis as an Autologous Source of Stem Cells for Tissue Engineering and Regenerative Medicine.
    Vapniarsky N; Arzi B; Hu JC; Nolta JA; Athanasiou KA
    Stem Cells Transl Med; 2015 Oct; 4(10):1187-98. PubMed ID: 26253713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Possible Muscle Repair in the Human Cardiovascular System.
    Sommese L; Zullo A; Schiano C; Mancini FP; Napoli C
    Stem Cell Rev Rep; 2017 Apr; 13(2):170-191. PubMed ID: 28058671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetically modified cells in regenerative medicine and tissue engineering.
    Sheyn D; Mizrahi O; Benjamin S; Gazit Z; Pelled G; Gazit D
    Adv Drug Deliv Rev; 2010 Jun; 62(7-8):683-98. PubMed ID: 20114067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RNA interference: the silent treatment.
    Clayton J
    Nature; 2004 Sep; 431(7008):599-605. PubMed ID: 15457267
    [No Abstract]   [Full Text] [Related]  

  • 54. Knocking down gene expression with dendritic vectors.
    Raviña M; Paolicelli P; Seijo B; Sanchez A
    Mini Rev Med Chem; 2010 Jan; 10(1):73-86. PubMed ID: 20380642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo.
    Kunze D; Wuttig D; Kausch I; Blietz C; Blumhoff L; Burmeister Y; Kraemer K; Fuessel S; Toma M; Schwenzer B; Meye A; Grimm MO; Hakenberg OW; Jocham D; Wirth MP
    Int J Oncol; 2008 May; 32(5):1049-56. PubMed ID: 18425331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes.
    Capi O; Gepstein L
    J Control Release; 2006 Nov; 116(2):211-8. PubMed ID: 17005287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting human telomerase by antisense oligonucleotides and ribozymes.
    Folini M; Pennati M; Zaffaroni N
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):605-12. PubMed ID: 12678727
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapeutic oligonucleotides: a review].
    Wang X; Xian J; Chen G; Peng H
    Sheng Wu Gong Cheng Xue Bao; 2018 May; 34(5):664-675. PubMed ID: 29893074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antisense inhibition: oligonucleotides, ribozymes, and siRNAs.
    Zhang YC; Taylor MM; Samson WK; Phillips MI
    Methods Mol Med; 2005; 106():11-34. PubMed ID: 15375310
    [No Abstract]   [Full Text] [Related]  

  • 60. Anti-HIV therapy with antisense oligonucleotides and ribozymes: realistic approaches or expensive myths?
    Akhtar S; Rossi JJ
    J Antimicrob Chemother; 1996 Aug; 38(2):159-65. PubMed ID: 8877530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.